| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On December 28, 2007
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1978N-0038
|
| Sunscreen Drug Products
|
|
|
|
|
| 1994D-0025
|
| Guidelines on the Voluntary Labeling Milk & Milk Products from Cows That Have Not Been Treated with rbSt or rbGH
|
|
|
|
|
| 1995S-0158
|
| Community Disclosure of Institutional Review Boards
|
|
|
|
|
| 1997D-0318
|
| Revised Precautionary Measure to Reduce Transmission of CJD
|
|
|
|
|
| 2005P-0450
|
| Revoke the GRAS Status of Salt, Set Ceilings on the Amount of Sodium in Processed Foods, Require a Health Warning on Packaged Salt, and Reduce the Daily Value for Sodium
|
|
|
|
|
| 2006N-0168
|
| Food Labeling: Reference Daily Intakes & Daily Reference Values
|
|
|
|
|
| 2006N-0466
|
| Exceptions or Alternatives to Labeling Requirements for Products Held by the Strategic National Stockpile
|
|
|
|
|
| 2007D-0481
|
| Prescription Drug User Fee Act (PDUFA) IV Information Technology Plan
|
|
|
|
|
| 2007P-0085
|
| Adopt Regulations of General Applicability to all Food Standards that would Permit Deviations from the Requirements of the Individual Food Standards of Identity
|
|
|
|
|
| 2007P-0499
|
| Determine whether a food-effect study should be required as part of the demonstration of bioequivalence for clozapine orally disintegrating tablets (ODT), 100 mg
|
|
|
|
|
| 2007P-0500
|
| Revoke the GRAS standing of the food additive Monosodium Glutamate
|
|
| |
|
| 1978N-0038
|
| Sunscreen Drug Products
|
|
|
|
|
| C 718
|
| S. P. F. Consulting Laboratories, Inc.
|
| Vol #:
|
| 176
|
|
|
|
|
| C 719
|
| Hirschhorn & Young Graphics
|
| Vol #:
|
| 176
|
|
|
|
|
| C 720
|
| Hirschhorn & Young Graphics
|
| Vol #:
|
| 176
|
|
|
|
|
| C 721
|
| L'oreal, USA Products, Inc.
|
| Vol #:
|
| 181
|
|
|
|
|
| 1994D-0025
|
| Guidelines on the Voluntary Labeling Milk & Milk Products from Cows That Have Not Been Treated with rbSt or rbGH
|
|
|
|
|
| ANS 5
|
| HHS/Director of Correspondence for the First Lady to Diane J. Solomon
|
| Vol #:
|
| 8
|
|
|
|
|
| 1995S-0158
|
| Community Disclosure of Institutional Review Boards
|
|
|
|
|
| SUP 53
|
| Concentric Medical
|
| Vol #:
|
| 56
|
|
|
|
|
| 1997D-0318
|
| Revised Precautionary Measure to Reduce Transmission of CJD
|
|
|
|
|
| AMD 1
|
| AABB
|
| Vol #:
|
| 4
|
|
|
|
|
| 2005P-0450
|
| Revoke the GRAS Status of Salt, Set Ceilings on the Amount of Sodium in Processed Foods, Require a Health Warning on Packaged Salt, and Reduce the Daily Value for Sodium
|
|
|
|
|
| C 1
|
| L. Menes
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006N-0168
|
| Food Labeling: Reference Daily Intakes & Daily Reference Values
|
|
|
|
|
| EXT 7
|
| National Fisheries Institute
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006N-0466
|
| Exceptions or Alternatives to Labeling Requirements for Products Held by the Strategic National Stockpile
|
|
|
|
|
| NFR 1
|
| FDA
|
| Vol #:
|
| 1
|
|
| |
|
| 2007D-0481
|
| Prescription Drug User Fee Act (PDUFA) IV Information Technology Plan
|
|
|
|
|
| GDL 1
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
|
|
| NAD 1
|
| FDA
|
| Vol #:
|
| 1
|
|
